The total return over the past 12 months is -61.15% vs. +16.94% for the S&P 500. So far it's up -57.86% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (61.15%) | +24.76% | (15.72%) | (1.06%) | +1.64% | N/A |
| Total Return CAGR | (61.15%) | +24.76% | (15.72%) | (1.06%) | +1.64% | N/A |
| Revenue CAGR | +10.99% | +16.83% | +15.80% | +17.02% | +20.30% | N/A |
| Net Income CAGR | (9.80%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (14.82%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (72.90%) | (1.05%) | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (71.95%) | (1.14%) | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Niagen Bioscience Inc (NAGE)
| Year | Start price | End price | NAGE Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $6.36 | $2.68 | (57.86%) | +14.51% | (72.37%) |
| 2025 | $5.31 | $6.36 | +19.77% | +17.72% | +2.05% |
| 2024 | $1.43 | $5.31 | +271.33% | +24.89% | +246.44% |
| 2023 | $1.68 | $1.43 | (14.88%) | +26.19% | (41.07%) |
| 2022 | $3.74 | $1.68 | (55.08%) | (18.17%) | (36.91%) |
| 2021 | $4.80 | $3.74 | (22.08%) | +28.74% | (50.82%) |
| 2020 | $4.31 | $4.80 | +11.37% | +18.37% | (7.00%) |
| 2019 | $3.43 | $4.31 | +25.66% | +31.22% | (5.56%) |
| 2018 | $5.88 | $3.43 | (41.67%) | (4.56%) | (37.11%) |
| 2017 | $3.31 | $5.88 | +77.64% | +21.70% | +55.94% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
